- A pharmaceutical company was developing a gene therapy for a rare sleep disorder
- Gene therapy represents paradigm shift requiring understanding of physician readiness for innovation
- The client was looking to develop hypothesized HCP segments to inform targeting and engagement strategies for the gene therapy pipeline, focusing on treatment philosophy and innovation adoption patterns.